|
XK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.88540000001236E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.372530E-04 |
| Normal-vs-Stage2 |
6.051600E-01 |
| Normal-vs-Stage3 |
6.22429999985741E-07 |
| Normal-vs-Stage4 |
7.37439997955391E-10 |
| Stage1-vs-Stage2 |
6.842000E-02 |
| Stage1-vs-Stage3 |
1.457840E-01 |
| Stage1-vs-Stage4 |
1.443120E-03 |
| Stage2-vs-Stage3 |
1.099640E-02 |
| Stage2-vs-Stage4 |
4.562300E-04 |
| Stage3-vs-Stage4 |
8.044400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.49929999995846E-06 |
| Normal-vs-AfricanAmerican |
3.001200E-04 |
| Normal-vs-Asian |
1.20400001080156E-09 |
| Caucasian-vs-AfricanAmerican |
5.080600E-01 |
| Caucasian-vs-Asian |
1.108040E-02 |
| AfricanAmerican-vs-Asian |
3.910800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.92729999999708E-05 |
| Normal-vs-Female |
1.68700999999549E-05 |
| Male-vs-Female |
6.806200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.940350E-03 |
| Normal-vs-Age(41-60Yrs) |
1.41129999997602E-06 |
| Normal-vs-Age(61-80Yrs) |
1.787450E-04 |
| Normal-vs-Age(81-100Yrs) |
5.082800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.593400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.007400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.088400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.364000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.887600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.915000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.94720026161599E-10 |
| Classical-VS-Follicular |
2.69959999998903E-06 |
| Classical-VS-Other |
9.764800E-01 |
| Classical-VS-Normal |
1.37440000047562E-07 |
| Tall-VS-Follicular |
5.340172748447E-14 |
| Tall-VS-Other |
2.162800E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.304770E-01 |
| Follicular-VS-Normal |
5.695400E-01 |
| Other-VS-Normal |
2.707700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.764970E-03 |
| Normal-vs-N1 |
4.26019997057381E-09 |
| N0-vs-N1 |
3.406700E-04 |
|
|
